Skip to main content
Top
Published in: BMC Infectious Diseases 1/2013

Open Access 01-12-2013 | Research article

Prevalence of measles antibodies among health care workers in Catalonia (Spain) in the elimination era

Authors: Luis Urbiztondo, Eva Borràs, Josep Costa, Sonia Broner, Magda Campins, José María Bayas, María Esteve, Angela Domínguez, the Working Group for the Study of the Immune Status in Healthcare Workers in Catalonia

Published in: BMC Infectious Diseases | Issue 1/2013

Login to get access

Abstract

Background

Interruption of measles transmission was achieved in Catalonia (Spain) in 2000. Six years later, a measles outbreak occurred between August 2006 and June 2007 with 381 cases, 11 of whom were health care workers (HCW).
The objective was to estimate susceptibility to measles in HCW and related demographic and occupational characteristics.

Methods

A measles seroprevalence study was carried out in 639 HCW from six public tertiary hospitals and five primary healthcare areas. Antibodies were tested using the Vircell Measles ELISA IgG Kit. Data were analyzed according to age, sex, type of HCW, type of centre and vaccination history.
The odds ratios (OR) and their 95% CI were calculated to determine the variables associated with antibody prevalence. OR were adjusted using logistic regression.
Positive predictive values (PPV) and the 95% confidence intervals (CI) of having two documented doses of a measles containing vaccine (MCV) for the presence of measles antibodies and of reporting a history of measles infection were calculated.

Results

The prevalence of measles antibodies in HCW was 98% (95% CI 96.6-98.9), and was lower in HCW born in 1981 or later, after the introduction of systematic paediatric vaccination (94.4%; 95% CI 86.4-98.5) and higher in HCW born between 1965 and 1980 (99.0%; 95% CI 97.0-99.8). Significant differences were found for HCW born in 1965–1980 with respect to those born in 1981 and after (adjusted OR of 5.67; 95% CI: 1.24-25.91).
A total of 187 HCW reported being vaccinated: the proportion of vaccinated HCW decreased with age. Of HCW who reported being vaccinated, vaccination was confirmed by the vaccination card in 49%. Vaccination with 2 doses was documented in only 50 HCW, of whom 48 had measles antibodies. 311 HCW reported a history of measles.
The PPV of having received two documented doses of MCV was 96% (95% CI 86.3-99.5) and the PPV of reporting a history of measles was 98.7% (95% CI 96.7-99.6).

Conclusions

Screening to detect HCW who lack presumptive evidence of immunity and vaccination with two doses of vaccine should be reinforced, especially in young workers, to minimize the risk of contracting measles and infecting the susceptible patients they care for.
Literature
2.
go back to reference Weber DJ, Rutala WA: Vaccine for healthcare workers. Vaccines. Edited by: Plotkin S, Orenstein W, Offit P. 2008, Philadelphia: Saunders Elsevier, 1453-1477. 5 Weber DJ, Rutala WA: Vaccine for healthcare workers. Vaccines. Edited by: Plotkin S, Orenstein W, Offit P. 2008, Philadelphia: Saunders Elsevier, 1453-1477. 5
3.
go back to reference Biellik RJ, Clements CJ: Strategies for minimizing nosocomial measles transmission. Bull World Health Organ. 1997, 75: 367-375.PubMedPubMedCentral Biellik RJ, Clements CJ: Strategies for minimizing nosocomial measles transmission. Bull World Health Organ. 1997, 75: 367-375.PubMedPubMedCentral
4.
go back to reference Botelho-Nevers E, Gautret P, Biellik RJ, Brouqui P: Nosocomial transmission of measles: an updated review. Vaccine. 2012, 30 (27): 3996-4001. 10.1016/j.vaccine.2012.04.023.CrossRefPubMed Botelho-Nevers E, Gautret P, Biellik RJ, Brouqui P: Nosocomial transmission of measles: an updated review. Vaccine. 2012, 30 (27): 3996-4001. 10.1016/j.vaccine.2012.04.023.CrossRefPubMed
5.
go back to reference Salleras L, Domínguez A, Batalla J, Corretger JM, Moraga F, Roca J, et al: L'eliminació del xarampió a Catalunya per a l'any 2000. Bases científiques i programa. 1999, Barcelona: Departament de Sanitat i Seguretat Socia Salleras L, Domínguez A, Batalla J, Corretger JM, Moraga F, Roca J, et al: L'eliminació del xarampió a Catalunya per a l'any 2000. Bases científiques i programa. 1999, Barcelona: Departament de Sanitat i Seguretat Socia
8.
go back to reference Domínguez A, Torner N, Barrabeig I, Rovira A, Rius C, et al: Large measles outbreak in a community with high vaccination coverage. Clin Infect Dis. 2008, 47: 1143-1149. 10.1086/592258.CrossRefPubMed Domínguez A, Torner N, Barrabeig I, Rovira A, Rius C, et al: Large measles outbreak in a community with high vaccination coverage. Clin Infect Dis. 2008, 47: 1143-1149. 10.1086/592258.CrossRefPubMed
9.
go back to reference Borràs E, Urbiztondo L, Costa J, Batalla J, Torner N, Plasencia A, et al: Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination. Epidemiol Infect. 2012, 140 (9): 1599-1606. 10.1017/S0950268811002184.CrossRefPubMed Borràs E, Urbiztondo L, Costa J, Batalla J, Torner N, Plasencia A, et al: Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination. Epidemiol Infect. 2012, 140 (9): 1599-1606. 10.1017/S0950268811002184.CrossRefPubMed
10.
go back to reference Torner N, Anton A, Barrabeig I, Lafuente S, Parron I, Arias C, Camps N, Costa J, Martínez A, Torra R, Godoy P, Minguell S, Ferrús G, Cabezas C, Domínguez A, the Measles Elimination Program Surveillance Network of Catalonia and Spain: Epidemiology of two large measles virus outbreaks in Catalonia: What a difference the month of administration of the first dose of vaccine makes. Hum Vaccin Immunother. 2013, 9 (3): 675-680.CrossRefPubMedPubMedCentral Torner N, Anton A, Barrabeig I, Lafuente S, Parron I, Arias C, Camps N, Costa J, Martínez A, Torra R, Godoy P, Minguell S, Ferrús G, Cabezas C, Domínguez A, the Measles Elimination Program Surveillance Network of Catalonia and Spain: Epidemiology of two large measles virus outbreaks in Catalonia: What a difference the month of administration of the first dose of vaccine makes. Hum Vaccin Immunother. 2013, 9 (3): 675-680.CrossRefPubMedPubMedCentral
11.
go back to reference Seo SK, Malak SF, Lim S, Eagan J, Spkowitz KA: Prevalence of measles antibody among young adult healthcare workers in a cancer hospital: 1980s versus 1989–1999. Infect Control Hosp Epidemiol. 2002, 23: 276-278. 10.1086/502049.CrossRefPubMed Seo SK, Malak SF, Lim S, Eagan J, Spkowitz KA: Prevalence of measles antibody among young adult healthcare workers in a cancer hospital: 1980s versus 1989–1999. Infect Control Hosp Epidemiol. 2002, 23: 276-278. 10.1086/502049.CrossRefPubMed
12.
go back to reference Asari S, Deguchi M, Tahara K, Taniike M, Toyokawa M, Nishi I, et al: Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in healthcare workers and evaluation of a vaccination program in a tertiary care hospital in Japan. Am J Infect Control. 2003, 31: 157-162. 10.1067/mic.2003.16.CrossRefPubMed Asari S, Deguchi M, Tahara K, Taniike M, Toyokawa M, Nishi I, et al: Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in healthcare workers and evaluation of a vaccination program in a tertiary care hospital in Japan. Am J Infect Control. 2003, 31: 157-162. 10.1067/mic.2003.16.CrossRefPubMed
13.
go back to reference Centers for Disease Prevention and Control: Recommended adult immunization schedule-United States, 2012. MMWR. 2012, 61: 1-7. Centers for Disease Prevention and Control: Recommended adult immunization schedule-United States, 2012. MMWR. 2012, 61: 1-7.
14.
go back to reference Domínguez A, Plans P, Costa J, Torner N, Cardeñosa N, Batalla J, et al: Sero-prevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis. 2006, 25: 310-317. 10.1007/s10096-006-0133-z.CrossRefPubMed Domínguez A, Plans P, Costa J, Torner N, Cardeñosa N, Batalla J, et al: Sero-prevalence of measles, rubella, and mumps antibodies in Catalonia, Spain: results of a cross-sectional study. Eur J Clin Microbiol Infect Dis. 2006, 25: 310-317. 10.1007/s10096-006-0133-z.CrossRefPubMed
16.
go back to reference Botelho-Nevers E, Cassir N, Minodier P, Laporte R, Gautret P, Badiaga S, Thiberville D, Ninove L, Charrel R, Brouqui P: Measles among healthcare workers: a potential for nosocomial outbreaks. Euro Surveill. 2011, 16 (2): Botelho-Nevers E, Cassir N, Minodier P, Laporte R, Gautret P, Badiaga S, Thiberville D, Ninove L, Charrel R, Brouqui P: Measles among healthcare workers: a potential for nosocomial outbreaks. Euro Surveill. 2011, 16 (2):
17.
go back to reference Martin R, Deshevoi S, Jankovic D, Goel A, Mercer D, Laurent E: Progress toward measles elimination - European Region, 2005–2008. MMWR. 2009, 58: 142-145. Martin R, Deshevoi S, Jankovic D, Goel A, Mercer D, Laurent E: Progress toward measles elimination - European Region, 2005–2008. MMWR. 2009, 58: 142-145.
19.
go back to reference Marshall T, Hlatswayo D, Schoub B: Nosocomial outbreaks-A potential threat to the elimination of measles?. J Infect Dis. 2003, 187 (Suppl 1): S97-S101.CrossRefPubMed Marshall T, Hlatswayo D, Schoub B: Nosocomial outbreaks-A potential threat to the elimination of measles?. J Infect Dis. 2003, 187 (Suppl 1): S97-S101.CrossRefPubMed
20.
go back to reference Nakano T: Measles outbreak in a Japanese hospital. Scand J Infect Dis. 2002, 34: 462-CrossRef Nakano T: Measles outbreak in a Japanese hospital. Scand J Infect Dis. 2002, 34: 462-CrossRef
21.
go back to reference Mendelson GM, Roth CE, Wreghitt TG, Brown NM, Ziegler E, Lever AM: Nosocomial transmission of measles to healthcare workers. Time for a national screening and immunization policy for NHS staff?. J Hosp Infect. 2000, 44: 154-155.CrossRefPubMed Mendelson GM, Roth CE, Wreghitt TG, Brown NM, Ziegler E, Lever AM: Nosocomial transmission of measles to healthcare workers. Time for a national screening and immunization policy for NHS staff?. J Hosp Infect. 2000, 44: 154-155.CrossRefPubMed
22.
go back to reference Curtale F, Perrelli F, Mantovani J, Cioffi Degli Atti M, Filia A, Nicoletti L, et al: Description of two measles outbreaks in the Lazio Region, Italy (2006–2007). Importance of pockets of low vaccine coverage in sustaining the infection. BMC Infect Dis. 2010, 10: 62-10.1186/1471-2334-10-62.CrossRefPubMedPubMedCentral Curtale F, Perrelli F, Mantovani J, Cioffi Degli Atti M, Filia A, Nicoletti L, et al: Description of two measles outbreaks in the Lazio Region, Italy (2006–2007). Importance of pockets of low vaccine coverage in sustaining the infection. BMC Infect Dis. 2010, 10: 62-10.1186/1471-2334-10-62.CrossRefPubMedPubMedCentral
23.
go back to reference Grgic-Vitek M, Frelih T, Ucakar V, Prosenc K, Ttomazic J, Petrovec M, Kraigher A: Spotlights on measles 2010: a cluster of measles in a hospital setting in Slovenia, March 2010. Euro Surveill. 2010, 15 (20): pii=19573- Grgic-Vitek M, Frelih T, Ucakar V, Prosenc K, Ttomazic J, Petrovec M, Kraigher A: Spotlights on measles 2010: a cluster of measles in a hospital setting in Slovenia, March 2010. Euro Surveill. 2010, 15 (20): pii=19573-
24.
go back to reference Chen SY, Anderson S, Kutty PK, Lugo F, McDonald M, Rota PA, et al: Health-care associated measles outbreak in the United States after an importation: challenges and economic impact. J Infect Dis. 2011, 203: 1517-1525. 10.1093/infdis/jir115.CrossRefPubMed Chen SY, Anderson S, Kutty PK, Lugo F, McDonald M, Rota PA, et al: Health-care associated measles outbreak in the United States after an importation: challenges and economic impact. J Infect Dis. 2011, 203: 1517-1525. 10.1093/infdis/jir115.CrossRefPubMed
25.
go back to reference Weston KM, Dwyer D, Tatnamohan M, McPhie K, Chan S-W, et al: Nosocomial and community transmission of measles virus genotype D8 imported by a returning traveller from Nepal. Commun Dis Intell. 2006, 30: 358-365. Weston KM, Dwyer D, Tatnamohan M, McPhie K, Chan S-W, et al: Nosocomial and community transmission of measles virus genotype D8 imported by a returning traveller from Nepal. Commun Dis Intell. 2006, 30: 358-365.
26.
go back to reference Centers for Disease Control and Prevention: Hospital-associated measles outbreak-Pennsylvania-March-April 2009. MMWR. 2012, 61: 30-32. Centers for Disease Control and Prevention: Hospital-associated measles outbreak-Pennsylvania-March-April 2009. MMWR. 2012, 61: 30-32.
27.
go back to reference Caputi G, Tafuri S, Chironna M, Martinelli D, Sallustio A, Falco A, et al: An outbreak of measles including nosocomial transmission in Apulia, south-east Italy, January- March 2008- A preliminary report. Euro Surveill. 2008, 13: 1-2. Caputi G, Tafuri S, Chironna M, Martinelli D, Sallustio A, Falco A, et al: An outbreak of measles including nosocomial transmission in Apulia, south-east Italy, January- March 2008- A preliminary report. Euro Surveill. 2008, 13: 1-2.
28.
go back to reference Choi WS, Sniadack DH, Jee Y, Go U-Y, So JS, Cho H, et al: Outbreak of measles in the republic of Korea, 2007: Importance of nosocomial transmission. J Infect Dis. 2011, 204 (supl 1): S483-S490.CrossRefPubMed Choi WS, Sniadack DH, Jee Y, Go U-Y, So JS, Cho H, et al: Outbreak of measles in the republic of Korea, 2007: Importance of nosocomial transmission. J Infect Dis. 2011, 204 (supl 1): S483-S490.CrossRefPubMed
29.
go back to reference Centers for Disease Control and Prevention: Immunization of Health-Care Personnel. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2011, 60 (RR-7): 1-45. Centers for Disease Control and Prevention: Immunization of Health-Care Personnel. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2011, 60 (RR-7): 1-45.
30.
go back to reference Follin P, Dotevall L, Jjertborn M, Khalid Y, Lijeqvist JA, Muntz S, et al: Effective control measures limited measles outbreak after extensive nosocomial exposures in January-February 2008 in Gothenburg, Sweden. Euro Surveill. 2008, 13: 1-5. Follin P, Dotevall L, Jjertborn M, Khalid Y, Lijeqvist JA, Muntz S, et al: Effective control measures limited measles outbreak after extensive nosocomial exposures in January-February 2008 in Gothenburg, Sweden. Euro Surveill. 2008, 13: 1-5.
31.
go back to reference Dinelli MI, Moreira TD, Paulino ER, da Rocha MC, Graciani FB, de Moraes-Pinto MI: Immune status and risk perception of acquisition of vaccine preventable diseases among health care workers. Am J Infect Control. 2009, 37: 858-860. 10.1016/j.ajic.2009.04.283.CrossRefPubMed Dinelli MI, Moreira TD, Paulino ER, da Rocha MC, Graciani FB, de Moraes-Pinto MI: Immune status and risk perception of acquisition of vaccine preventable diseases among health care workers. Am J Infect Control. 2009, 37: 858-860. 10.1016/j.ajic.2009.04.283.CrossRefPubMed
32.
go back to reference Ziegler E, Roth C, Wreghitt T: Prevalence of measles susceptibility among health care workers in a UK hospital. Does the UK need to introduce a measles policy for its health care workers?. Occup Med. 2003, 53: 398-402. 10.1093/occmed/kqg077.CrossRef Ziegler E, Roth C, Wreghitt T: Prevalence of measles susceptibility among health care workers in a UK hospital. Does the UK need to introduce a measles policy for its health care workers?. Occup Med. 2003, 53: 398-402. 10.1093/occmed/kqg077.CrossRef
Metadata
Title
Prevalence of measles antibodies among health care workers in Catalonia (Spain) in the elimination era
Authors
Luis Urbiztondo
Eva Borràs
Josep Costa
Sonia Broner
Magda Campins
José María Bayas
María Esteve
Angela Domínguez
the Working Group for the Study of the Immune Status in Healthcare Workers in Catalonia
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2013
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-13-391

Other articles of this Issue 1/2013

BMC Infectious Diseases 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.